Dear MRI Insider,
It's fair to say the medical profession is still learning about thalassemia, and MRI is proving crucial in this process, as shown by new research from Italy.
A national study has revealed important new information about this disorder. The results were presented at the annual congress of the European Society of Cardiology (ESC) in Rome, and they're worth a close look. To do so, click here.
Concern over DNA double-strand breaks in T lymphocytes after cardiac MRI scans prompted a group at Zurich University Hospital to compare the carcinogenic potential of ultralow-dose coronary CTA with that of routine cardiac MR. They unveiled their findings at ESC 2016. Click here for the full story.
As every musculoskeletal radiologist will tell you, MRI is the key modality for diagnosing injuries in elite athletes. So it's no great surprise that staff in the polyclinic at the Rio Olympics made full use of two MRI systems. Get the details here.
Meanwhile, Swedish investigators have used MRI to acquire 4D flow and morphological data from patients with mild chronic ischemic heart disease. They found that alterations in multidimensional intraventricular blood flow patterns and energetics may detect left-ventricular dysfunction, even in subtle or subclinical left-ventricular remodeling and dysfunction. To learn more, click here.
A new investigational technique is enabling German researchers to perform MR-guided liver biopsies of lesions that can't be seen using other modalities and that are inaccessible in most MRI scanners. Click here for the details.
Please scroll through the links below for the rest of the news in your MRI Community.
